Question Title

* 1. Given the need to intensify the glucose-lowering regimen (not at target glycated haemoglobin) and the clinical characteristics of the patient, which could be an appropriate drug to be added to the ongoing therapeutic scheme?

Question Title

* 2. In the case that the same patient presents also an eGFR between 60-90 (mL/min/1.73 m2), which measure should be adopted?

To see the correct answers please click "Next"
( Privacy & Cookie Notice